it was interesting/confusing that the BSE price rallied on Friday
I'm very confused about target value.
But here are my overall thoughts:
The Toliara part of the deal is NPV valued at $2Bn USD;
The original EFR value was $1Bn USD;
The downstream value of the REE production from EFR is comparable size to Lynas, which is capped at ~$4Bn USD;
That's a total of $7Bn USD on a sum of the parts valuation while the post merger entity will be capped at $1Bn; there's a further 6 or 7 times upside at these prices.
- Forums
- ASX - By Stock
- Ann: Court approves convening of Scheme Meeting
it was interesting/confusing that the BSE price rallied on...
Featured News
Add BSE (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online